Periodic Reporting for period 1 - PROTACs (Design, synthesis and biological evaluation of PROteolysis-TArgeting Chimeric (PROTAC) molecules as anticancer agents)

Cancer diseases represent critical medical challenges. According to the recent estimates, 1 958 310 new cancer cases and 609 820 cancer deaths are projected to occur in the United States in 2023 [1]. On the other hand, 2 740 000 new cancer cases and 1 290 000 cancer-related...